What is the equity of Orexo this year?
Orexo has equity of -126.3 M SEK this year.
Orexo Equity 2025
Orexo Equity
-126.3 M SEK
Ticker
ORX.ST
ISIN
SE0000736415
WKN
A0HG6G
In 2025, Orexo's equity was -126.3 M SEK, a -314.43% increase from the 58.9 M SEK equity in the previous year.
Orexo Aktienanalyse
What does Orexo do?
Orexo AB is a Swedish pharmaceutical company that was founded in 1995 and is headquartered in Uppsala. The company focuses on the development of medications for the treatment of pain and addiction disorders. Business model: Orexo's business model is based on the development of innovative medications and their marketing in the global market. The company specializes in the development of medications based on opioid technology. Divisions: Orexo operates in two main business areas: Pharmaceuticals and digital therapeutics. Pharmaceuticals: In the pharmaceutical division, Orexo is primarily involved in the development of medications used in the treatment of pain and addiction disorders. Some of the best-known medications include: - Zubsolv: a medication for the treatment of opioid addiction - Abstral: a fast-acting pain medication for cancer patients - Edluar: a sleep medication for the treatment of sleep disorders Orexo's pharmaceuticals are distributed in over 60 countries worldwide and have already helped many patients alleviate their symptoms. Digital therapeutics: Orexo has expanded its business model and offers digital therapeutics - apps that contribute to improving the success of pain and addiction disorder treatment. One example is the app "Orexo Digital," which helps patients better monitor their medication and document the progress of their treatment. The app is free and can be downloaded by patients who have been prescribed medications from Orexo. History: Orexo was founded in 1995 by a team of researchers from Uppsala University. The company initially focused on the development of medications for the treatment of inflammatory diseases and allergies. In 2003, the company decided to concentrate on the development of medications in pain and addiction treatment. The first products in this area were the pain medication Abstral and the substitution medication Zubsolv. In the following years, the company grew rapidly and opened additional locations in the United States, United Kingdom, and France. Orexo works closely with key players in the healthcare sector to ensure that its medications are accessible to patients worldwide. Products: Abstral: a medication for the treatment of acute and chronic severe pain. It is taken sublingually and acts quickly. Zubsolv: a medication for the treatment of opioid addiction. It contains the active ingredients buprenorphine and naloxone and can alleviate withdrawal symptoms in opioid addiction. Edluar: a sleep medication for the treatment of sleep disorders. It contains the active ingredient zolpidem and is taken sublingually. Orexo Digital: an app to support patients in the treatment of pain and addiction disorders. It enables the monitoring of treatment progress and provides helpful advice for improving treatment success. Conclusion: Orexo is an innovative pharmaceutical company specializing in the development of medications for the treatment of pain and addiction disorders. The company has made a name for itself with its unique opioid technology and offers successful products such as Abstral and Zubsolv. With its expansion into the field of digital therapeutics, Orexo also demonstrates that it remains at the forefront of technology and innovation. Orexo ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Orexo's Equity
Orexo's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Orexo's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Orexo's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Orexo's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Orexo’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Orexo stock
What was the equity of Orexo compared to the previous year?
The equity of Orexo has increased/decreased by -314.43% decreased compared to the previous year.
What impact does a high equity have on investors of Orexo?
A high equity is advantageous for investors of Orexo as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Orexo?
A low equity can be a risk for investors of Orexo, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Orexo affect the company?
An increase in equity of Orexo can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Orexo affect the company?
A reduction in equity of Orexo can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Orexo?
Some factors that can affect the equity of Orexo include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Orexo so important for investors?
The equity of Orexo is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Orexo take to change the equity?
To change equity, Orexo can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Orexo pay?
Over the past 12 months, Orexo paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Orexo is expected to pay a dividend of 0 SEK.
What is the dividend yield of Orexo?
The current dividend yield of Orexo is .
When does Orexo pay dividends?
Orexo pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Orexo?
Orexo paid dividends every year for the past 0 years.
What is the dividend of Orexo?
For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.
In which sector is Orexo located?
Orexo is assigned to the 'Health' sector.
Wann musste ich die Aktien von Orexo kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Orexo from 7/3/2025 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 7/3/2025.
When did Orexo pay the last dividend?
The last dividend was paid out on 7/3/2025.
What was the dividend of Orexo in the year 2024?
In the year 2024, Orexo distributed 0 SEK as dividends.
In which currency does Orexo pay out the dividend?
The dividends of Orexo are distributed in SEK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Orexo
Our stock analysis for Orexo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orexo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
